Combination treatment with ethyl pyruvate and IGF-I exerts neuroprotective effects against brain injury in a rat model of neonatal hypoxic-ischemic encephalopathy

Rong,Zhihui; Pan,Rui; Chang,Liwen; Lee,Weihua

doi:10.3892/ijmm.2015.2219

Combination treatment with ethyl pyruvate and IGF-I exerts neuroprotective effects against brain injury in a rat model of neonatal hypoxic-ischemic encephalopathy

Authors:
- Zhihui Rong
- Rui Pan
- Liwen Chang
- Weihua Lee
View Affiliations

Affiliations: Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 46202, USA
Published online on: May 22, 2015 https://doi.org/10.3892/ijmm.2015.2219
Pages: 195-203
Copyright: © Rong et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Neonatal hypoxic-ischemic (HI) brain injury causes severe brain damage in newborns. Following HI injury, rapidly accumulating oxidants injure neurons and interrupt ongoing developmental processes. The antioxidant, sodium pyruvate, has been shown to reduce neuronal injury in neonatal rats under conditions of oxygen glucose deprivation (OGD) and HI injury. In this study, we evaluated the effects of ethyl pyruvate (EP) and insulin‑like growth factor‑I (IGF‑I) alone or in combination in a similar setting. For this purpose, we used an in vitro model involving primary neonatal rat cortical neurons subjected to OGD for 2.5 h and an in vivo model involving unilateral carotid ligation in rats on post-natal day 7 with exposure to 8% hypoxia for 2.5 h. The cultured neurons were examined by lactate dehydrogenase (LDH) and cell viability assays. For the in vivo experiments, behavioral development was evaluated by the foot fault test at 4 weeks of recovery. 2,3,5‑Triphenyltetrazolium chloride monohydrate and cresyl violet staining were used to evaluate HI injury. The injured neurons were Fluoro‑Jade B-labeled, new neuroprecursors were double labeled with bromodeoxyuridine (BrdU) and doublecortin, new mature neurons were BrdU-labeled and neuronal nuclei were labeled by immunofluorescence. Under conditions of OGD, the LDH levels increased and neuronal viability decreased. Treatment with 0.5 mM EP or 25 ng/ml IGF‑I protected the neurons (P<0.05), exerting additive effects. Similarly, either the early administration of EP or delayed treatment with IGF‑I protected the neonatal rat brains against HI injury and improved neurological performance and these effects were also additive. This effect may be the result of reduced neuronal injury, and enhanced neurogenesis and maturation. On the whole, our findings demonstrate that the combination of the early administration of EP with delayed treatment with IGF‑I exerts neuroprotective effects against HI injury in neonatal rat brains.

View Figures

View References

1	Ikonomidou C, Mosinger JL, Salles KS, Labruyere J and Olney JW: Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N-methyl-aspartate neurotoxicity. J Neurosci. 9:2809–2818. 1989.PubMed/NCBI
2	Jiang X, Mu D, Manabat C, et al: Differential vulnerability of immature murine neurons to oxygen-glucose deprivation. Exp Neurol. 190:224–232. 2004. View Article : Google Scholar : PubMed/NCBI
3	Ikonomidou C and Kaindl AM: Neuronal death and oxidative stress in the developing brain. Antioxid Redox Signal. 14:1535–1550. 2010. View Article : Google Scholar : PubMed/NCBI
4	Berger R and Garnier Y: Perinatal brain injury. J Perinat Med. 28:261–285. 2000.PubMed/NCBI
5	du Plessis AJ and Volpe JJ: Perinatal brain injury in the preterm and term newborn. Curr Opin Neurol. 15:151–157. 2002. View Article : Google Scholar : PubMed/NCBI
6	Logitharajah P, Rutherford MA and Cowan FM: Hypoxic-ischemic encephalopathy in preterm infants: antecedent factors, brain imaging, and outcome. Pediatr Res. 66:222–229. 2009. View Article : Google Scholar : PubMed/NCBI
7	Vannucci RC: Hypoxic-ischemic encephalopathy. Am J Perinatol. 17:113–120. 2000. View Article : Google Scholar : PubMed/NCBI
8	Russo VC, Gluckman PD, Feldman EL and Werther GA: The insulin-like growth factor system and its pleiotropic functions in brain. Endocr Rev. 26:916–943. 2005. View Article : Google Scholar : PubMed/NCBI
9	Aberg ND, Brywe KG and Isgaard J: Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. ScientificWorldJournal. 6:53–80. 2006. View Article : Google Scholar : PubMed/NCBI
10	Guan J, Bennet L, George S, et al: Insulin-like growth factor-1 reduces postischemic white matter injury in fetal sheep. J Cereb Blood Flow Metab. 21:493–502. 2001. View Article : Google Scholar : PubMed/NCBI
11	Guan J: Insulin-like growth factor-1 and its derivatives: potential pharmaceutical application for ischemic brain injury. Recent Pat CNS Drug Discov. 3:112–127. 2008. View Article : Google Scholar : PubMed/NCBI
12	Desagher S, Glowinski J and Premont J: Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J Neurosci. 17:9060–9067. 1997.PubMed/NCBI
13	Mazzio E and Soliman KF: Pyruvic acid cytoprotection against 1-methyl-4-phenylpyridinium, 6-hydroxydopamine and hydrogen peroxide toxicities in vitro. Neurosci Lett. 337:77–80. 2003. View Article : Google Scholar : PubMed/NCBI
14	Pan R, Rong Z, She Y, Cao Y, Chang LW and Lee WH: Sodium pyruvate reduces hypoxic-ischemic injury to neonatal rat brain. Pediatr Res. 72:479–489. 2012. View Article : Google Scholar : PubMed/NCBI
15	Shen H, Hu X, Liu C, et al: Ethyl pyruvate protects against hypoxic-ischemic brain injury via anti-cell death and anti-inflammatory mechanisms. Neurobiol Dis. 37:711–722. 2010. View Article : Google Scholar :
16	Rong Z, Pan R, Xu Y, Zhang C, Cao Y and Liu D: Hesperidin pretreatment protects hypoxia-ischemic brain injury in neonatal rat. Neuroscience. 255:292–299. 2013. View Article : Google Scholar : PubMed/NCBI
17	Goldberg MP and Choi DW: Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury. J Neurosci. 13:3510–3524. 1993.PubMed/NCBI
18	Rice JE III, Vannucci RC and Brierley JB: The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol. 9:131–141. 1981. View Article : Google Scholar : PubMed/NCBI
19	Zhong J, Zhao L, Du Y, Wei G, Yao WG and Lee WH: Delayed IGF-1 treatment reduced long-term hypoxia-ischemia-induced brain damage and improved behavior recovery of immature rats. Neurol Res. 31:483–489. 2009. View Article : Google Scholar : PubMed/NCBI
20	Northington FJ, Chavez-Valdez R and Martin LJ: Neuronal cell death in neonatal hypoxia-ischemia. Ann Neurol. 69:743–758. 2011. View Article : Google Scholar : PubMed/NCBI
21	Perlman JM: Intervention strategies for neonatal hypoxic-ischemic cerebral injury. Clin Ther. 28:1353–1365. 2006. View Article : Google Scholar : PubMed/NCBI
22	Savman K and Brown KL: Treating neonatal brain injury - promise and inherent research challenges. Recent Pat Inflamm Allergy Drug Discov. 4:16–24. 2010. View Article : Google Scholar
23	Buonocore G and Groenendaal F: Anti-oxidant strategies. Semin Fetal Neonatal Med. 12:287–295. 2007. View Article : Google Scholar : PubMed/NCBI
24	Hobbs CE and Oorschot DE: Neonatal rat hypoxia-ischemia: long-term rescue of striatal neurons and motor skills by combined antioxidant-hypothermia treatment. Brain Pathol. 18:443–454. 2008. View Article : Google Scholar : PubMed/NCBI
25	Cruz RJ Jr, Harada T, Sasatomi E and Fink MP: Effects of ethyl pyruvate and other α-keto carboxylic acid derivatives in a rat model of multivisceral ischemia and reperfusion. J Surg Res. 165:151–157. 2011. View Article : Google Scholar
26	Kao KK and Fink MP: The biochemical basis for the anti-inflammatory and cytoprotective actions of ethyl pyruvate and related compounds. Biochem Pharmacol. 80:151–159. 2010. View Article : Google Scholar : PubMed/NCBI
27	Gressens P, Le Verche V, Fraser M, Rousset CI, Schwendimann L, Bennet L, George SA, Wang X, Mallard C, Tilley BC, et al: Pitfalls in the quest of neuroprotectants for the perinatal brain. Dev Neurosci. 33:189–198. 2011. View Article : Google Scholar : PubMed/NCBI
28	Werner H and Leroith D: Insulin and insulin-like growth factor receptors in the brain: Physiological and pathological aspects. Eur Neuropsychopharmacol. Jan 31–2014.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
29	Satar M, Ozcan K, Yapicioglu H and Narli N: Serum insulin-like growth factor 1 and growth hormone levels of hypoxic-ischemic newborns. Biol Neonate. 85:15–20. 2004. View Article : Google Scholar
30	Lee WH, Wang GM, Seaman LB and Vannucci SJ: Coordinate IGF-I and IGFBP5 gene expression in perinatal rat brain after hypoxia-ischemia. J Cereb Blood Flow Metab. 16:227–236. 1996. View Article : Google Scholar : PubMed/NCBI
31	Clawson TF, Vannucci SJ, Wang GM, Seaman LB, Yang XL and Lee WH: Hypoxia-ischemia-induced apoptotic cell death correlates with IGF-I mRNA decrease in neonatal rat brain. Biol Signals Recept. 8:281–293. 1999. View Article : Google Scholar : PubMed/NCBI
32	Brywe KG, Mallard C, Gustavsson M, et al: IGF-I neuroprotection in the immature brain after hypoxia-ischemia, involvement of Akt and GSK3beta? Eur J Neurosci. 21:1489–1502. 2005. View Article : Google Scholar : PubMed/NCBI
33	Lin S, Fan LW, Rhodes PG and Cai Z: Intranasal administration of IGF-1 attenuates hypoxic-ischemic brain injury in neonatal rats. Exp Neurol. 217:361–370. 2009. View Article : Google Scholar : PubMed/NCBI
34	Wood TL, Loladze V, Altieri S, Gangoli N, Levison SW, Brywe KG, Mallard C and Hagberg H: Delayed IGF-1 administration rescues oligodendrocyte progenitors from glutamate-induced cell death and hypoxic-ischemic brain damage. Dev Neurosci. 29:302–310. 2007. View Article : Google Scholar : PubMed/NCBI
35	Pazos MR, Cinquina V, Gomez A, et al: Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function. Neuropharmacology. 63:776–783. 2012. View Article : Google Scholar : PubMed/NCBI
36	Towfighi J, Mauger D, Vannucci RC and Vannucci SJ: Influence of age on the cerebral lesions in an immature rat model of cerebral hypoxia-ischemia: a light microscopic study. Brain Res Dev Brain Res. 100:149–160. 1997. View Article : Google Scholar : PubMed/NCBI
37	Shrivastava K, Chertoff M, Llovera G, Recasens M and Acarin L: Short and long-term analysis and comparison of neurodegeneration and inflammatory cell response in the ipsilateral and contralateral hemisphere of the neonatal mouse brain after hypoxia/ischemia. Neurol Res Int. 2012:7815122012. View Article : Google Scholar : PubMed/NCBI
38	Dudek H, Datta SR, Franke TF, et al: Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science. 275:661–665. 1997. View Article : Google Scholar : PubMed/NCBI
39	Aberg MA, Aberg ND, Hedbacker H, Oscarsson J and Eriksson PS: Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus. J Neurosci. 20:2896–2903. 2000.
40	D’Ercole AJ, Ye P and O’Kusky JR: Mutant mouse models of insulin-like growth factor actions in the central nervous system. Neuropeptides. 36:209–220. 2002. View Article : Google Scholar
41	Gao X, Enikolopov G and Chen J: Moderate traumatic brain injury promotes proliferation of quiescent neural progenitors in the adult hippocampus. Exp Neurol. 219:516–523. 2009. View Article : Google Scholar : PubMed/NCBI
42	Bartley J, Soltau T, Wimborne H, et al: BrdU-positive cells in the neonatal mouse hippocampus following hypoxic-ischemic brain injury. BMC Neurosci. 6:152005. View Article : Google Scholar : PubMed/NCBI
43	Bayer SA: Development of the hippocampal region in the rat. I. Neurogenesis examined with 3H-thymidine autoradiography. J Comp Neurol. 190:87–114. 1980. View Article : Google Scholar : PubMed/NCBI